Cancer patient Jere Carpentier would prefer taking a pill to having intravenous chemotherapy in a doctor’s office. But she and other people like her are being denied access to newer oral chemotherapy drugs or are required to shoulder hefty out-of-pocket costs. The problem? The IV treatments are covered under a patient’s medical plan but the pills are paid for by a patient’s drug plan, which tends to be far less generous. (Producer: Renato Perez)
Related Article: A Bitter Pill To Swallow
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the core operating programs at KFF—an independent source of health policy research, polling, and journalism. Learn more about KFF.Some elements may be removed from this article due to republishing restrictions. If you have questions about available photos or other content, please contact khnweb@kff.org.
